Moving targets: From channel blockers to trafficking blockers?

Voltage-gated Ca V 1.2 channels are among the most intensively studied ion channels in cardiovascular physiology, including arterial myocytes.By governing calcium influx into arterial smooth muscle cells, they are essential determinants of vascular tone, blood pressure regulation and tissue perfusion.Consequently, Ca V 1.2 channels have long been a major therapeutic target, with calcium channel blockers remaining a cornerstone of cardiovascular medicine and hypertension management.Yet, despite decades of investigation into channel biophysics and pharmacology, Ca V 1.2 channels have largely been studied as stationary entities.What if they are constantly on the move?In this issue of The Journal of Physiology, Martin-Aragon Baudel and colleagues provide an unprecedented view of vascular Ca V 1.2 channel behaviour in real time (Martin-Aragon Baudel et al., 2026).Using a complementary experimental strategy, the authors first examined Ca V 1.2 dynamics in unpassaged cultured aortic arterial myocytes expressing a smooth muscle Ca V 1.2 isoform tagged with mCherry (Ca V 1.2SM-mCherry), and subsequently in freshly isolated arterial myocytes from a novel Ca V 1.2-mClover2 knock-in mouse that enables visualization of endogenous channels in living tissue.This technical achievement is not merely a new imaging tool; it provides the first opportunity to observe endogenous vascular Ca V 1.2 channels as they move and reorganize in their native environment.Much of